Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ACRS

ACRS News

Newswire

11:02

Aclaris Therapeutics shares jump 12.61% intraday on positive Phase 2a trial results for ATI-2138 and strong cash runway into 2028.

07:53

Aclaris Therapeutics Sees 62% Q4 Gain, Still Down 83% Over Three Years

07:36

Aclaris Therapeutics to participate in 3 healthcare conferences in November.

07:31

Aclaris Therapeutics to Present at Three Healthcare Conferences in November.

07:48

Aclaris Therapeutics: HC Wainwright Raises PT to $16 from $15.

View More

About ACRS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More